With BioHale® Trehalose, the latest addition to the BioHale® portfolio line, DFE Pharma expands its offering of stabilizers for biologics while providing further security of supply. Goch, Germany (15 ...

Goch, Germany- July 5 th, 2022 - DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, announced today the expansion of its Dry Powder Inhalation (DPI) portfolio with the ...

GARDENA, Calif.--(BUSINESS WIRE)--Spectrum Chemical Mfg. Corp., a leading global provider of specialty, fine and cGMP chemicals, as well as laboratory equipment and supplies, has entered into a new ...

As of February 2013 DFE Pharma offers two grades of Microcrystalline Cellulose (MCC) - Pharmacel ® 101 and Pharmacel ® 102 - to its global customers. MCC is, together with lactose and ...

DFE’s new line will offer market purity and low endotoxin excipients for use in formulation, while providing drug developers and manufacturers high-quality excipient technology and services. DFE ...

DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, has achieved the ISO 22301 certification for Business Continuity Management Systems (BCMS) at its head office at Goch, ...

DFE Pharma, a provider of pharma and nutraceutical excipient solutions, opened its new Closer to the Formulator (C2F), a Center of Excellence, in the Genome Valley here. The C2F helps pharmaceutical ...

We develop, produce and supply excipients for use in oral solid dose and dry powder inhalation, but as a supplier of complete solutions we do a lot more than that. We work closely with pharmaceutical ...

DFE Pharma, a global leader in pharmaceutical excipients, has launched EcoLact 2030, a pioneer initiative within the industry, designed to bring transparency and verified sustainability to its current ...

The drive to help clients accomplish more has made DFE Pharma an enduring global leader in excipient solutions. With more than 100 years of experience and a reputation for continuous innovation, the ...